Did you know ? If you order before Friday 14h we deliver 90PCT of the the time next Tuesday, GENTAUR another in time delivery

Secreted frizzled-related protein 4 (sFRP-4) (Frizzled protein, human endometrium) (FrpHE)

 SFRP4_HUMAN             Reviewed;         346 AA.
Q6FHJ7; B4DYC1; O14877; Q05BG7; Q1ZYW2; Q4G124; Q6FHM0; Q6PD64;
15-MAR-2005, integrated into UniProtKB/Swiss-Prot.
15-MAR-2005, sequence version 2.
05-DEC-2018, entry version 145.
RecName: Full=Secreted frizzled-related protein 4;
Short=sFRP-4;
AltName: Full=Frizzled protein, human endometrium;
Short=FrpHE;
Flags: Precursor;
Name=SFRP4; Synonyms=FRPHE;
Homo sapiens (Human).
Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
Catarrhini; Hominidae; Homo.
NCBI_TaxID=9606;
[1]
NUCLEOTIDE SEQUENCE [MRNA].
TISSUE=Endometrium;
PubMed=10211996;
Abu-Jawdeh G.M., Comella N., Brown L.F., Tognazzi K., Kocher O.;
"Differential expression of frpHE: a novel human stromal protein of
the secreted frizzled gene family, during the endometrial cycle and
malignancy.";
Lab. Invest. 79:439-447(1999).
[2]
NUCLEOTIDE SEQUENCE [MRNA], AND POSSIBLE FUNCTION AS A PHOSPHATURIC
AGENT.
TISSUE=Mesenchymal tumor;
PubMed=12952927; DOI=10.1172/JCI18563;
Berndt T., Craig T.A., Bowe A.E., Vassiliadis J., Reczek D.,
Finnegan R., Jan De Beur S.M., Schiavi S.C., Kumar R.;
"Secreted frizzled-related protein 4 is a potent tumor-derived
phosphaturic agent.";
J. Clin. Invest. 112:785-794(2003).
[3]
NUCLEOTIDE SEQUENCE [MRNA], AND VARIANT THR-320.
TISSUE=Ovary;
Drake J.M., Zeps N., Dharmarajan A.;
"Open reading frame of the human secreted frizzled related protein
4.";
Submitted (FEB-2006) to the EMBL/GenBank/DDBJ databases.
[4]
NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA], AND VARIANTS THR-320 AND
LYS-340.
TISSUE=Testis;
PubMed=14702039; DOI=10.1038/ng1285;
Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A.,
Sudo H., Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M.,
Takahashi M., Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y.,
Abe K., Kamihara K., Katsuta N., Sato K., Tanikawa M., Yamazaki M.,
Ninomiya K., Ishibashi T., Yamashita H., Murakawa K., Fujimori K.,
Tanai H., Kimata M., Watanabe M., Hiraoka S., Chiba Y., Ishida S.,
Ono Y., Takiguchi S., Watanabe S., Yosida M., Hotuta T., Kusano J.,
Kanehori K., Takahashi-Fujii A., Hara H., Tanase T.-O., Nomura Y.,
Togiya S., Komai F., Hara R., Takeuchi K., Arita M., Imose N.,
Musashino K., Yuuki H., Oshima A., Sasaki N., Aotsuka S.,
Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y.,
Fujimori Y., Komiyama M., Tashiro H., Tanigami A., Fujiwara T.,
Ono T., Yamada K., Fujii Y., Ozaki K., Hirao M., Ohmori Y.,
Kawabata A., Hikiji T., Kobatake N., Inagaki H., Ikema Y., Okamoto S.,
Okitani R., Kawakami T., Noguchi S., Itoh T., Shigeta K., Senba T.,
Matsumura K., Nakajima Y., Mizuno T., Morinaga M., Sasaki M.,
Togashi T., Oyama M., Hata H., Watanabe M., Komatsu T.,
Mizushima-Sugano J., Satoh T., Shirai Y., Takahashi Y., Nakagawa K.,
Okumura K., Nagase T., Nomura N., Kikuchi H., Masuho Y., Yamashita R.,
Nakai K., Yada T., Nakamura Y., Ohara O., Isogai T., Sugano S.;
"Complete sequencing and characterization of 21,243 full-length human
cDNAs.";
Nat. Genet. 36:40-45(2004).
[5]
NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
Ebert L., Schick M., Neubert P., Schatten R., Henze S., Korn B.;
"Cloning of human full open reading frames in Gateway(TM) system entry
vector (pDONR201).";
Submitted (JUN-2004) to the EMBL/GenBank/DDBJ databases.
[6]
NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
Kalnine N., Chen X., Rolfs A., Halleck A., Hines L., Eisenstein S.,
Koundinya M., Raphael J., Moreira D., Kelley T., LaBaer J., Lin Y.,
Phelan M., Farmer A.;
"Cloning of human full-length CDSs in BD Creator(TM) system donor
vector.";
Submitted (OCT-2004) to the EMBL/GenBank/DDBJ databases.
[7]
NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA], AND VARIANT THR-320.
PubMed=12690205; DOI=10.1126/science.1083423;
Scherer S.W., Cheung J., MacDonald J.R., Osborne L.R., Nakabayashi K.,
Herbrick J.-A., Carson A.R., Parker-Katiraee L., Skaug J., Khaja R.,
Zhang J., Hudek A.K., Li M., Haddad M., Duggan G.E., Fernandez B.A.,
Kanematsu E., Gentles S., Christopoulos C.C., Choufani S.,
Kwasnicka D., Zheng X.H., Lai Z., Nusskern D.R., Zhang Q., Gu Z.,
Lu F., Zeesman S., Nowaczyk M.J., Teshima I., Chitayat D., Shuman C.,
Weksberg R., Zackai E.H., Grebe T.A., Cox S.R., Kirkpatrick S.J.,
Rahman N., Friedman J.M., Heng H.H.Q., Pelicci P.G., Lo-Coco F.,
Belloni E., Shaffer L.G., Pober B., Morton C.C., Gusella J.F.,
Bruns G.A.P., Korf B.R., Quade B.J., Ligon A.H., Ferguson H.,
Higgins A.W., Leach N.T., Herrick S.R., Lemyre E., Farra C.G.,
Kim H.-G., Summers A.M., Gripp K.W., Roberts W., Szatmari P.,
Winsor E.J.T., Grzeschik K.-H., Teebi A., Minassian B.A., Kere J.,
Armengol L., Pujana M.A., Estivill X., Wilson M.D., Koop B.F.,
Tosi S., Moore G.E., Boright A.P., Zlotorynski E., Kerem B.,
Kroisel P.M., Petek E., Oscier D.G., Mould S.J., Doehner H.,
Doehner K., Rommens J.M., Vincent J.B., Venter J.C., Li P.W.,
Mural R.J., Adams M.D., Tsui L.-C.;
"Human chromosome 7: DNA sequence and biology.";
Science 300:767-772(2003).
[8]
NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA], AND VARIANTS THR-320 AND
LYS-340.
TISSUE=Brain;
PubMed=15489334; DOI=10.1101/gr.2596504;
The MGC Project Team;
"The status, quality, and expansion of the NIH full-length cDNA
project: the Mammalian Gene Collection (MGC).";
Genome Res. 14:2121-2127(2004).
[9]
TISSUE SPECIFICITY.
PubMed=10728394; DOI=10.1016/S0008-6363(99)00376-4;
Schumann H., Holtz J., Zerkowski H.R., Hatzfeld M.;
"Expression of secreted frizzled related proteins 3 and 4 in human
ventricular myocardium correlates with apoptosis related gene
expression.";
Cardiovasc. Res. 45:720-728(2000).
[10]
SUBCELLULAR LOCATION, AND TISSUE SPECIFICITY.
PubMed=19480240;
Drake J., Shearwood A.M., White J., Friis R., Zeps N., Charles A.,
Dharmarajan A.;
"Expression of secreted frizzled-related protein 4 (SFRP4) in primary
serous ovarian tumours.";
Eur. J. Gynaecol. Oncol. 30:133-141(2009).
[11]
INVOLVEMENT IN PYL.
PubMed=27355534; DOI=10.1056/NEJMoa1509342;
Simsek Kiper P.O., Saito H., Gori F., Unger S., Hesse E., Yamana K.,
Kiviranta R., Solban N., Liu J., Brommage R., Boduroglu K., Bonafe L.,
Campos-Xavier B., Dikoglu E., Eastell R., Gossiel F., Harshman K.,
Nishimura G., Girisha K.M., Stevenson B.J., Takita H., Rivolta C.,
Superti-Furga A., Baron R.;
"Cortical-Bone Fragility--Insights from sFRP4 Deficiency in Pyle's
Disease.";
N. Engl. J. Med. 374:2553-2562(2016).
-!- FUNCTION: Soluble frizzled-related proteins (sFRPS) function as
modulators of Wnt signaling through direct interaction with Wnts.
They have a role in regulating cell growth and differentiation in
specific cell types (By similarity). SFRP4 plays a role in bone
morphogenesis. May also act as a regulator of adult uterine
morphology and function. May also increase apoptosis during
ovulation possibly through modulation of FZ1/FZ4/WNT4 signaling
(By similarity). Has phosphaturic effects by specifically
inhibiting sodium-dependent phosphate uptake (PubMed:12952927).
{ECO:0000250|UniProtKB:Q9JLS4, ECO:0000250|UniProtKB:Q9Z1N6,
ECO:0000269|PubMed:12952927}.
-!- SUBCELLULAR LOCATION: Secreted {ECO:0000269|PubMed:19480240}.
Note=Cytoplasmic in ovarian tumor cells.
-!- TISSUE SPECIFICITY: Expressed in mesenchymal cells. Highly
expressed in the stroma of proliferative endometrium. Expressed in
cardiomyocytes. Shows moderate to strong expression in ovarian
tumors with expression increasing as the tumor stage increases. In
ovarian tumors, expression levels are inversely correlated with
expression of CTNNB1 (at protein level).
{ECO:0000269|PubMed:10728394, ECO:0000269|PubMed:19480240}.
-!- INDUCTION: Increased levels in failing myocardium. Up-regulated in
several tumor types including ostomalacia-associated tumors and
endometrial and breast carcinomas.
-!- DOMAIN: The FZ domain is involved in binding with Wnt ligands.
{ECO:0000250}.
-!- DISEASE: Pyle disease (PYL) [MIM:265900]: A disorder characterized
by cortical-bone thinning, limb deformity, bone fragility and
fractures. {ECO:0000269|PubMed:27355534}. Note=The disease is
caused by mutations affecting the gene represented in this entry.
-!- SIMILARITY: Belongs to the secreted frizzled-related protein
(sFRP) family. {ECO:0000305}.
-!- SEQUENCE CAUTION:
Sequence=BAG63683.1; Type=Erroneous initiation; Evidence={ECO:0000305};
-!- WEB RESOURCE: Name=Atlas of Genetics and Cytogenetics in Oncology
and Haematology;
URL="http://atlasgeneticsoncology.org/Genes/SFRP4ID42277ch7p14.html";
-----------------------------------------------------------------------
Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
Distributed under the Creative Commons Attribution (CC BY 4.0) License
-----------------------------------------------------------------------
EMBL; AF026692; AAC04617.1; -; mRNA.
EMBL; DQ420628; ABD83351.1; -; mRNA.
EMBL; AK302357; BAG63683.1; ALT_INIT; mRNA.
EMBL; CR541731; CAG46532.1; -; mRNA.
EMBL; CR541755; CAG46555.1; -; mRNA.
EMBL; BT019679; AAV38485.1; -; mRNA.
EMBL; CH236951; EAL23981.1; -; Genomic_DNA.
EMBL; BC047684; AAH47684.1; -; mRNA.
EMBL; BC058911; AAH58911.1; -; mRNA.
CCDS; CCDS5453.1; -.
RefSeq; NP_003005.2; NM_003014.3.
UniGene; Hs.658169; -.
ProteinModelPortal; Q6FHJ7; -.
BioGrid; 112322; 19.
IntAct; Q6FHJ7; 22.
MINT; Q6FHJ7; -.
STRING; 9606.ENSP00000410715; -.
GlyConnect; 1726; -.
iPTMnet; Q6FHJ7; -.
PhosphoSitePlus; Q6FHJ7; -.
BioMuta; SFRP4; -.
DMDM; 61216780; -.
EPD; Q6FHJ7; -.
PaxDb; Q6FHJ7; -.
PeptideAtlas; Q6FHJ7; -.
PRIDE; Q6FHJ7; -.
ProteomicsDB; 66293; -.
DNASU; 6424; -.
Ensembl; ENST00000436072; ENSP00000410715; ENSG00000106483.
GeneID; 6424; -.
KEGG; hsa:6424; -.
UCSC; uc003tfo.5; human.
CTD; 6424; -.
DisGeNET; 6424; -.
EuPathDB; HostDB:ENSG00000106483.11; -.
GeneCards; SFRP4; -.
H-InvDB; HIX0033524; -.
HGNC; HGNC:10778; SFRP4.
HPA; HPA009712; -.
HPA; HPA050585; -.
MalaCards; SFRP4; -.
MIM; 265900; phenotype.
MIM; 606570; gene.
neXtProt; NX_Q6FHJ7; -.
OpenTargets; ENSG00000106483; -.
Orphanet; 3005; Pyle disease.
PharmGKB; PA35694; -.
eggNOG; KOG3577; Eukaryota.
eggNOG; ENOG410XRC8; LUCA.
GeneTree; ENSGT00940000160766; -.
HOVERGEN; HBG070536; -.
InParanoid; Q6FHJ7; -.
KO; K02185; -.
OMA; YAPICAL; -.
OrthoDB; EOG091G0BGB; -.
PhylomeDB; Q6FHJ7; -.
ChiTaRS; SFRP4; human.
GeneWiki; SFRP4; -.
GenomeRNAi; 6424; -.
PRO; PR:Q6FHJ7; -.
Proteomes; UP000005640; Chromosome 7.
Bgee; ENSG00000106483; Expressed in 178 organ(s), highest expression level in connective tissue.
CleanEx; HS_SFRP4; -.
ExpressionAtlas; Q6FHJ7; baseline and differential.
Genevisible; Q6FHJ7; HS.
GO; GO:0009986; C:cell surface; IDA:BHF-UCL.
GO; GO:0005737; C:cytoplasm; IDA:UniProtKB.
GO; GO:0005615; C:extracellular space; IDA:BHF-UCL.
GO; GO:0005634; C:nucleus; IDA:BHF-UCL.
GO; GO:0017147; F:Wnt-protein binding; IDA:MGI.
GO; GO:0060349; P:bone morphogenesis; IMP:UniProtKB.
GO; GO:0060070; P:canonical Wnt signaling pathway; IBA:GO_Central.
GO; GO:0030154; P:cell differentiation; IEA:UniProtKB-KW.
GO; GO:0090090; P:negative regulation of canonical Wnt signaling pathway; IDA:BHF-UCL.
GO; GO:0008285; P:negative regulation of cell proliferation; IMP:BHF-UCL.
GO; GO:0043433; P:negative regulation of DNA-binding transcription factor activity; IDA:BHF-UCL.
GO; GO:2000051; P:negative regulation of non-canonical Wnt signaling pathway; ISS:UniProtKB.
GO; GO:2000119; P:negative regulation of sodium-dependent phosphate transport; IDA:BHF-UCL.
GO; GO:0030178; P:negative regulation of Wnt signaling pathway; NAS:ParkinsonsUK-UCL.
GO; GO:0035567; P:non-canonical Wnt signaling pathway; IBA:GO_Central.
GO; GO:0055062; P:phosphate ion homeostasis; IDA:BHF-UCL.
GO; GO:0043065; P:positive regulation of apoptotic process; IMP:BHF-UCL.
GO; GO:0090263; P:positive regulation of canonical Wnt signaling pathway; IGI:MGI.
GO; GO:0045606; P:positive regulation of epidermal cell differentiation; IDA:BHF-UCL.
GO; GO:0010628; P:positive regulation of gene expression; IDA:BHF-UCL.
GO; GO:1902174; P:positive regulation of keratinocyte apoptotic process; IDA:BHF-UCL.
GO; GO:0002092; P:positive regulation of receptor internalization; IDA:BHF-UCL.
GO; GO:0030510; P:regulation of BMP signaling pathway; ISS:UniProtKB.
GO; GO:0009725; P:response to hormone; NAS:BHF-UCL.
Gene3D; 1.10.2000.10; -; 1.
InterPro; IPR015526; Frizzled/SFRP.
InterPro; IPR020067; Frizzled_dom.
InterPro; IPR036790; Frizzled_dom_sf.
InterPro; IPR001134; Netrin_domain.
InterPro; IPR018933; Netrin_module_non-TIMP.
InterPro; IPR026560; SFRP4.
InterPro; IPR008993; TIMP-like_OB-fold.
PANTHER; PTHR11309; PTHR11309; 1.
PANTHER; PTHR11309:SF7; PTHR11309:SF7; 1.
Pfam; PF01392; Fz; 1.
Pfam; PF01759; NTR; 1.
SMART; SM00643; C345C; 1.
SMART; SM00063; FRI; 1.
SUPFAM; SSF50242; SSF50242; 1.
SUPFAM; SSF63501; SSF63501; 1.
PROSITE; PS50038; FZ; 1.
PROSITE; PS50189; NTR; 1.
1: Evidence at protein level;
Complete proteome; Developmental protein; Differentiation;
Disulfide bond; Glycoprotein; Polymorphism; Reference proteome;
Secreted; Signal; Wnt signaling pathway.
SIGNAL 1 18 {ECO:0000255}.
CHAIN 19 346 Secreted frizzled-related protein 4.
/FTId=PRO_0000032550.
DOMAIN 19 139 FZ. {ECO:0000255|PROSITE-
ProRule:PRU00090}.
DOMAIN 178 307 NTR. {ECO:0000255|PROSITE-
ProRule:PRU00295}.
CARBOHYD 38 38 N-linked (GlcNAc...) asparagine.
{ECO:0000255}.
CARBOHYD 68 68 N-linked (GlcNAc...) asparagine.
{ECO:0000255}.
CARBOHYD 116 116 N-linked (GlcNAc...) asparagine.
{ECO:0000255}.
CARBOHYD 194 194 N-linked (GlcNAc...) asparagine.
{ECO:0000255}.
CARBOHYD 240 240 N-linked (GlcNAc...) asparagine.
{ECO:0000255}.
DISULFID 24 85 {ECO:0000250}.
DISULFID 32 78 {ECO:0000250}.
DISULFID 69 108 {ECO:0000250}.
DISULFID 97 136 {ECO:0000250}.
DISULFID 101 125 {ECO:0000250}.
VARIANT 320 320 P -> T (in dbSNP:rs1802073).
{ECO:0000269|PubMed:12690205,
ECO:0000269|PubMed:14702039,
ECO:0000269|PubMed:15489334,
ECO:0000269|Ref.3}.
/FTId=VAR_051964.
VARIANT 340 340 R -> K (in dbSNP:rs1802074).
{ECO:0000269|PubMed:14702039,
ECO:0000269|PubMed:15489334}.
/FTId=VAR_051965.
CONFLICT 19 19 V -> M (in Ref. 5; CAG46532).
{ECO:0000305}.
CONFLICT 77 77 L -> F (in Ref. 1; AAC04617).
{ECO:0000305}.
CONFLICT 141 141 A -> V (in Ref. 5; CAG46555).
{ECO:0000305}.
SEQUENCE 346 AA; 39827 MW; 75D04089E446CE80 CRC64;
MFLSILVALC LWLHLALGVR GAPCEAVRIP MCRHMPWNIT RMPNHLHHST QENAILAIEQ
YEELVDVNCS AVLRFFLCAM YAPICTLEFL HDPIKPCKSV CQRARDDCEP LMKMYNHSWP
ESLACDELPV YDRGVCISPE AIVTDLPEDV KWIDITPDMM VQERPLDVDC KRLSPDRCKC
KKVKPTLATY LSKNYSYVIH AKIKAVQRSG CNEVTTVVDV KEIFKSSSPI PRTQVPLITN
SSCQCPHILP HQDVLIMCYE WRSRMMLLEN CLVEKWRDQL SKRSIQWEER LQEQRRTVQD
KKKTAGRTSR SNPPKPKGKP PAPKPASPKK NIKTRSAQKR TNPKRV


Related products :

Catalog number Product name Quantity
EIAAB38041 Frizzled protein, human endometrium,FrpHE,FRPHE,Homo sapiens,Human,Secreted frizzled-related protein 4,SFRP4,sFRP-4
bs-1331P Peptides: sFRP-4(Secreted frizzled-related protein 4; Frizzled protein, human endometrium) Protein Length:12-25 amino acids. 200ug lyophilized
EIAAB38042 Frizzled-related protein 1b,FRP1B,FRP-1b,Homo sapiens,Human,SARP3,SARP-3,Secreted apoptosis-related protein 3,Secreted frizzled-related protein 5,SFRP5,sFRP-5
18-003-43293 Secreted frizzled-related protein 1 - sFRP-1; Frizzled-related protein 1; FRP-1; Secreted apoptosis-related protein 2; SARP-2 Polyclonal 0.1 mg Protein A
18-001-30017 Secreted frizzled-related protein 5 - sFRP-5; Secreted apoptosis-related protein 3; SARP-3; Frizzled-related protein 1b; FRP-1b Polyclonal 0.1 mg
EIAAB38036 FIZ,FRE,Frezzled,Fritz,Frizzled-related protein 1,FRP,FRZB,FRZB1,FrzB-1,Homo sapiens,Human,Secreted frizzled-related protein 3,SFRP3,sFRP-3
EIAAB38038 Fiz,Fre,Frezzled,Fritz,Frizzled-related protein 1,Frzb,Frzb1,FrzB-1,Mouse,Mus musculus,Secreted frizzled-related protein 3,Sfrp3,sFRP-3
EIAAB38037 Bos taurus,Bovine,Frizzled-related protein 1,FRZB,FRZB1,FrzB-1,Secreted frizzled-related protein 3,SFRP3,sFRP-3
EIAAB38026 FRP,FRP1,FRP-1,Homo sapiens,Human,SARP2,SARP-2,Secreted apoptosis-related protein 2,Secreted frizzled-related protein 1,SFRP1,sFRP-1
31-085 Secreted frizzled-related protein 1 (SFRP1) is a member of the SFRP family that contains a cysteine-rich domain homologous to the putative Wnt-binding site of Frizzled proteins. SFRPs act as soluble m 0.1 mg
EIAAB38032 FKSG12,FRP2,FRP-2,Homo sapiens,Human,SARP1,SARP-1,Secreted apoptosis-related protein 1,Secreted frizzled-related protein 2,SFRP2,sFRP-2,UNQ361_PRO697
EIAAB38027 Bos taurus,Bovine,Frizzled in aorta protein,FRZA,FrzA protein,Secreted frizzled-related protein 1,SFRP1,sFRP-1
C544 Human Secreted Frizzled-Related Protein 2 sFRP-2 l0
CC82 Human Secreted Frizzled-Related Protein 2 sFRP-2 50
C640 Secreted Frizzled-Related Protein 2 sFRP-2 500
C640 Secreted Frizzled-Related Protein 2 sFRP-2 lmg
EIAAB38035 Chicken,Frizzled-related protein 1,FRZB,FrzB-1,Gallus gallus,Secreted frizzled-related protein 3,SFRP3,sFRP-3
C640 Recombinant Human Secreted Frizzled-Related Protein 2 per sFRP-2 per SARP1 (C-6His) 10ug
EIAAB38031 Mouse,Mus musculus,Protein SDF5,Sarp1,SARP-1,Sdf5,Secreted apoptosis-related protein 1,Secreted frizzled-related protein 2,Sfrp2,sFRP-2
EIAAB38044 Bos taurus,Bovine,Secreted frizzled-related protein 5,SFRP5,sFRP-5
EIAAB38043 Mouse,Mus musculus,Secreted frizzled-related protein 5,Sfrp5,sFRP-5
EIAAB38028 Mouse,Mus musculus,Secreted frizzled-related protein 1,Sfrp1,sFRP-1
EIAAB38029 Rat,Rattus norvegicus,Secreted frizzled-related protein 1,Sfrp1,sFRP-1
EIAAB38040 Ddc4,DDC-4 protein,Frp,Rat,Rattus norvegicus,Secreted frizzled-related protein 4,Sfrp4,sFRP-4
EIAAB38039 FRP-4,Mouse,Mus musculus,Secreted frizzled-related sequence protein 4,Sfrp4,sFRP-4


 

GENTAUR Belgium BVBA BE0473327336
Voortstraat 49, 1910 Kampenhout BELGIUM
Tel 0032 16 58 90 45

Fax 0032 16 50 90 45
info@gentaur.com | Gentaur | Gentaur





GENTAUR Ltd.
Unicorn House, Station Cl
Hertfordshire, Potters Bar EN6 1TL
Whetstone London N20 9BH
Tel 020 3393 8531 Fax 020 8445 9411
uk@gentaur.com | Gentaur | Gentaur

 

 




GENTAUR France SARL
9, rue Lagrange, 75005 Paris
Tel 01 43 25 01 50

Fax 01 43 25 01 60
RCS Paris B 484 237 888

SIRET 48423788800017
RIB 30004 00187 00010092253 10
BNP PARIBAS PARIS PL MAUBERT BIC BNPAFRPPPRG
IBAN FR76 3000 4001 8700 0100 9225 310
france@gentaur.com | Gentaur | Gentaur

GENTAUR GmbH
Marienbongard 20
52062 Aachen Deutschland
Support Karolina Elandt
Tel: +49 0241 40 08 90 86, +49 0241 95 78 94 78, +49 0241 40 08 90 86
Fax: (+49) 241 56 00 47 88

Logistic :0241 40 08 90 86
Bankleitzahl 39050000
IBAN lautet DE8839050000107569353
Handelsregister Aachen HR B 16058
Umsatzsteuer-Identifikationsnummer *** DE 815175831
Steuernummer 201/5961/3925
de@gentaur.com | Gentaur | Gentaur

GENTAUR U.S.A
Genprice Inc, Logistics
547, Yurok Circle
San Jose, CA 95123
CA 95123
Tel (408) 780-0908,
Fax (408) 780-0908,
sales@genprice.com

Genprice Inc, Invoices and accounting
6017 Snell Ave, Ste 357
San Jose, CA 95123




GENTAUR Nederland BV
NL850396268B01 KVK nummer 52327027
Kuiper 1
5521 DG Eersel Nederland
Tel:  0208-080893  Fax: 0497-517897
nl@gentaur.com | Gentaur | Gentaur
IBAN: NL04 RABO 0156 9854 62   SWIFT RABONL2U






GENTAUR Spain
tel:0911876558
spain@gentaur.com | Gentaur | Gentaur






ГЕНТАУЪР БЪЛГАРИЯ
ID # 201 358 931 /BULSTAT
София 1000, ул. "Граф Игнатиев" 53 вх. В, ет. 2
Tel 0035924682280 Fax 0035924808322
e-mail: Sofia@gentaur.com | Gentaur | Gentaur
IBAN: BG11FINV91501014771636
BIC: FINVBGSF

GENTAUR Poland Sp. z o.o.


ul. Grunwaldzka 88/A m.2
81-771 Sopot, Poland
TEL Gdansk 058 710 33 44 FAX  058 710 33 48              

poland@gentaur.com | Gentaur | Gentaur

Other countries

Österreich +43720880899

Canada Montreal +15149077481

Ceská republika Praha +420246019719

Danmark +4569918806

Finland Helsset +358942419041

Magyarország Budapest +3619980547

Ireland Dublin+35316526556

Luxembourg+35220880274

Norge Oslo+4721031366

Sverige Stockholm+46852503438

Schweiz Züri+41435006251

US New York+17185132983

GENTAUR Italy
SRL IVA IT03841300167
Piazza Giacomo Matteotti, 6
24122 Bergamo Tel 02 36 00 65 93
Fax 02 36 00 65 94
italia@gentaur.com | Gentaur | Gentaur